🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Steven Cohen’s KNSA Holdings & Trades

First Buy
Q2 2018
Duration Held
18 Quarters
Largest Add
Q1 2025
+1.15 M Shares
Current Position
548,496 Shares
$40.92 M Value

Steven Cohen's KNSA Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 548,496 shares of Kiniksa Pharmaceuticals International, plc (KNSA) worth $40.92 M, representing 0.05% of the portfolio. First purchased in 2018-Q2, this medium-term investment has been held for 18 quarters.

Based on 13F filings, Steven Cohen has maintained a strategic position in KNSA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 1.15 M shares. Largest reduction occurred in Q2 2022, reducing 329,798 shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's Kiniksa Pharmaceuticals International plc (KNSA) Holding Value Over Time

Track share changes against reported price movement

Quarterly Kiniksa Pharmaceuticals International plc (KNSA) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 -110,997 Reduce 16.83% 548,496 $74.61
Q2 2026 +18,535 Add 2.89% 659,493 $63.95
Q1 2026 -156,179 Reduce 19.59% 640,958 $48.15
Q4 2025 +230,210 Add 40.61% 797,137 $41.25
Q3 2025 -281,622 Reduce 33.19% 566,927 $38.83
Q2 2025 -300,862 Reduce 26.18% 848,549 $27.67
Q1 2025 +1.15 M New Buy 1.15 M $22.21
Q2 2022 -329,798 Sold Out 0 $0.00
Q1 2022 -68,554 Reduce 17.21% 329,798 $9.94
Q4 2021 +23,252 Add 6.20% 398,352 $11.77
Q3 2021 +375,100 New Buy 375,100 $11.39
Q2 2021 -219,800 Sold Out 0 $0.00
Q1 2021 +219,800 New Buy 219,800 $18.51
Q4 2019 -140,000 Sold Out 0 $0.00
Q3 2019 +105,000 Add 300.00% 140,000 $8.51
Q2 2019 +35,000 New Buy 35,000 $13.54
Q3 2018 -5,000 Sold Out 0 $0.00
Q2 2018 +5,000 New Buy 5,000 $17.40

Steven Cohen's Kiniksa Pharmaceuticals International plc Investment FAQs

Steven Cohen first purchased Kiniksa Pharmaceuticals International, plc (KNSA) in Q2 2018, acquiring 5,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held Kiniksa Pharmaceuticals International, plc (KNSA) for 18 quarters since Q2 2018.

Steven Cohen's largest addition to Kiniksa Pharmaceuticals International, plc (KNSA) was in Q1 2025, adding 1,149,411 shares worth $25.53 M.

According to the latest 13F filing for Q3 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 548,496 shares of Kiniksa Pharmaceuticals International, plc (KNSA), valued at approximately $40.92 M.

As of the Q3 2026 filing, Kiniksa Pharmaceuticals International, plc (KNSA) represents approximately 0.05% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in Kiniksa Pharmaceuticals International, plc (KNSA) was 1,149,411 shares, as reported at the end of Q1 2025.